New incident report
Incident Report Number: 2021-4522
Registrant Reference Number: 2021-US-018883 and 2021-US-018898
Registrant Name (Full Legal Name no abbreviations): Wellmark International
Address: 100 Stone Road West, Suite 111
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G 5L3
Domestic Animal
Country: UNITED STATES
Prov / State: OKLAHOMA
PMRA Registration No. PMRA Submission No. EPA Registration No. 2724-454
Product Name: Zodiac Fleatrol Fogger
Other (specify)
AerosolUnknown
Unknown
Animal's Owner
Dog / Chien
Bloodhound
1
Female
6
31.752
kg
Unknown
Unknown / Inconnu
Unknown / Inconnu
System
Persisted until death
No
No
Died
Other / Autre
specify Unknown
(eg. description of the frequency and severity of the symptoms
On an unspecified date the dog developed symptoms. On 09 Jun 2021, the dog died. Following the dog's death, the animal owner found a canister of the product under the dog's kennel. There are 3 other dogs involved in the case; one other dog developed the same clinical signs and died (see included subform), the other two dogs developed the same symptoms. No further information is expected.
Death
Assessment: This product has a wide margin of safety. Respiratory irritation may occur if inhaled, ocular irritation may occur with ocular contact, and GI upset may occur if ingested. Ocular changes (secondary to irritation) and diarrhea may be attributable to this product, though further information about the time frame is required to assess relationship. Neither seizure activity nor death is expected. Other causes for the clinical signs including infection (such as distemper), exposure to other products, and possible malicious poisoning (per animal owner) remain in strong consideration. There was limited information about exposure to the product in these cases. Veterinary examination and treatment as well as necropsy may have been able to provide further information about the cause of the clinical signs and death, but these were not pursued by the animal owner. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.
Animal's Owner
Dog / Chien
Miniature Schnauzer
1
Female
6
6.804
kg
Unknown
Unknown / Inconnu
Unknown / Inconnu
System
Persisted until death
No
No
Died
Other / Autre
specify Unknown
(eg. description of the frequency and severity of the symptoms
On an unspecified date the dog developed symptoms. On 09 Jun 2021, the dog died. Following the dog's death, the animal owner found a canister of the product under the dog's kennel. There are 3 other dogs involved in the case; one other dog developed the same clinical signs and died (see included subform), the other two dogs developed the same symptoms. No further information is expected.
Death
Assessment: This product has a wide margin of safety. Respiratory irritation may occur if inhaled, ocular irritation may occur with ocular contact, and GI upset may occur if ingested. Ocular changes (secondary to irritation) and diarrhea may be attributable to this product, though further information about the time frame is required to assess relationship. Neither seizure activity nor death is expected. Other causes for the clinical signs including infection (such as distemper), exposure to other products, and possible malicious poisoning (per animal owner) remain in strong consideration. There was limited information about exposure to the product in these cases. Veterinary examination and treatment as well as necropsy may have been able to provide further information about the cause of the clinical signs and death, but these were not pursued by the animal owner. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.